GlassScriptPhysician profile
Steven D Grossinger
NPI 1134102957
$3,171.07
in general payments reported to CMS, 2019-2025
34 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $76.54 · 2021: $699 · 2022: $725 · 2023: $64.06 · 2024: $434 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $792.00 | 2021-2025 | |
| Pfizer INC. | $327.40 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $317.41 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $197.21 | 2022 | |
| Boston Scientific Corporation | $196.94 | 2025 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $178.21 | 2020-2024 | Emgality, Reyvow |
| Teva Pharmaceuticals USA, INC. | $148.17 | 2019-2022 | |
| Lundbeck LLC | $107.30 | 2024-2025 | Vyepti |
| Spr Therapeutics, INC | $80.06 | 2024 | Sprint Pns System |
| Medtronic, INC. | $78.33 | 2025 | Inceptiv |
| International Rehabilitative Sciences, INC | $68.35 | 2021-2025 | Rs-4i Plus With Intersperse |
| Ossur Americas, INC. | $61.95 | 2025 | Unloader One X |
| Novartis Pharmaceuticals Corporation | $59.64 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $56.99 | 2025 | Dysport |
| Impel Pharmaceuticals LLC | $53.41 | 2025 | Trudhesa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $50.11 | 2022-2025 | Tirosint, Licart, Flector |
| Trice Medical, INC. | $46.97 | 2025 | |
| Supernus Pharmaceuticals, INC. | $36.49 | 2019-2021 | |
| Amgen INC. | $31.08 | 2022 | |
| Abbott Laboratories | $27.98 | 2025 | Eterna |
| Vertical Pharmaceuticals, LLC | $23.86 | 2019 | |
| Fidia Pharma USA INC. | $23.59 | 2023 | Hymovis |
| Si-Bone, INC. | $21.04 | 2024 | |
| Arbor Pharmaceuticals, INC. | $20.76 | 2020 | |
| Grt US Holding, INC. | $20.65 | 2021 | |
| Stryker Corporation | $19.36 | 2025 | Spinejack |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.31 | 2025 | Relistor |
| Scilex Pharmaceuticals INC. | $17.50 | 2022 | |
| Axsome Therapeutics, INC. | $16.90 | 2025 | Symbravo |
| Collegium Pharmaceutical, INC. | $16.48 | 2022 | |
| Arteriocyte Medical Systems, INC. | $16.08 | 2019 | |
| Eisai INC. | $15.45 | 2022 | |
| Biodelivery Sciences International, INC. | $12.53 | 2019 | |
| Foundation Fusion Solutions, LLC | $11.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Grossinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.